Imaging device stocks lagged in 1997

Article

Shares of medical imaging device companies lagged behind almost all other healthcare sectors in 1997, according to a year-end review of the performance of healthcare stocks conducted by WDI Healthcare Markets Group of Hilton Head, SC. WDI's imaging

Shares of medical imaging device companies lagged behind almost all other healthcare sectors in 1997, according to a year-end review of the performance of healthcare stocks conducted by WDI Healthcare Markets Group of Hilton Head, SC. WDI's imaging devices segment fell 9% for the year, compared with an overall rise of 10% for healthcare stocks in general. Only two healthcare sectors, managed care and diagnostics, turned in worse performances.

The few stellar performers in WDI's imaging devices index included ATL Ultrasound, which rose 48%, and OEC Medical Systems, which climbed 33%. Trex Medical rose 7% and Norland Medical Systems climbed 11%. The index covers 25 public companies, including Acuson, Hologic, Lunar, ADAC Laboratories, and Fischer Imaging.

For most of these firms, it was tough sailing on the stock market, even though the medical imaging market posted a rebound in 1997. Part of the reason for the lower performance is that Wall Street has little patience for companies that turn in financial results even slightly shy of analysts' expectations, according to John Cumming, CEO of WDI.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.